The Akita Prefectural Government has announced a high-level delegation, led by Governor Kenta Suzuki, to visit Taiwan and Hong Kong from July 19 to 23. The mission aims to enhance inbound tourism and expand the export channels of Akita's premium products, such as Akita Beef, Shirakami Negi, and local sake. The delegation will commence their journey on July 19, traveling […]

JCB, the international payment brand from Japan, is celebrating its 30th anniversary in the Philippines in 2026, coinciding with the 70th anniversary of diplomatic relations between Japan and the Philippines. This dual celebration underscores the enduring partnership between the two nations, with JCB playing a significant role in fostering cultural and economic ties. Since entering the Philippine market in 1996, […]

TANAKA PRECIOUS METAL TECHNOLOGIES Co., Ltd. has commenced operations of the 'TANAKA H2 Nexus,' one of Japan's largest 500 kW pure hydrogen fuel cell power generation facilities, at its Shonan Fuel Cell Power Plant in Hiratsuka, Kanagawa Prefecture. The facility, operational since July 8, 2026, underscores TANAKA's commitment to advancing a hydrogen society by serving as both a material supplier […]

Eisai Co., Ltd. and Biogen Inc. have announced encouraging findings from their Lecanemab in Early Alzheimer's Disease (LEADER) Study, revealing that 82.5% of participants either remained stable or showed improvement over an average of 17 months of therapy. The results, presented at the Alzheimer's Association International Conference 2026, indicate that LEQEMBI treatment may help slow cognitive decline and maintain daily […]

Eisai Co., Ltd. has announced promising findings for its investigational anti-MTBR antibody, etalanetug, which demonstrated a reduction in plasma eMTBR-tau243, a key biomarker associated with Alzheimer's disease (AD) tau tangle pathology. The results were shared at the Alzheimer’s Association International Conference 2026. Etalanetug targets the microtubule-binding region of tau protein, potentially preventing the progression of tau pathology in the brain. […]

The U.S. Food and Drug Administration has approved a supplemental Biologics License Application for a subcutaneous form of lecanemab, branded as LEQEMBI IQLIK, for the treatment of early Alzheimer's disease, Eisai Co., Ltd. and Biogen Inc. announced. This approval introduces a once-weekly, at-home administration option via an autoinjector, offering a convenient alternative to intravenous dosing from the start of treatment. […]

NEC Corporation has announced the development of a pioneering technology that utilizes proprietary artificial intelligence to rapidly create highly detailed 3D models from video footage captured by general-purpose cameras, such as those found on smartphones. This innovation, developed in collaboration with the Keio AI Research Center, can generate 3D models in as little as one minute, even in dynamic environments […]

Hitachi Rail has been awarded the EcoVadis Platinum Medal, placing it among the top 1% of businesses assessed globally by EcoVadis over the past year. This accolade underscores the strength of Hitachi Rail's sustainability management system and its commitment to responsible business practices, environmental stewardship, ethical conduct, and supply chain transparency. The EcoVadis Platinum Medal is the highest level of […]

Anime Tokyo Station, an exhibition center dedicated to Japanese anime, has reached a significant milestone by welcoming its 300,000th visitor since its opening in October 2023. The facility, operated by the Tokyo Metropolitan Government and the Association of Japanese Animations, aims to promote the global appeal of Japanese anime. The milestone was achieved on June 20, 2026, with the 300,000th […]

Fujitsu Limited has unveiled its AI-driven Modernization Service in Japan, aimed at supporting sustainable growth for businesses and organizations. The service combines Fujitsu's expertise in system integration with generative AI to automate and optimize modernization efforts, focusing on rewrite and rehost strategies. The service leverages multiple AI models and the expertise of specialized engineers to shorten migration periods by approximately […]

ANA Akindo Co., Ltd., in collaboration with Mombetsu City in Hokkaido, has launched a joint inbound tourism campaign to boost travel to Mombetsu, spearheaded by All Nippon Airways Co., Ltd. (ANA). The initiative, which began on July 14, 2026, features special promotional fares for travelers from Singapore, Thailand, Hong Kong SAR, and the Philippines. The campaign offers travelers the opportunity […]

Anime Tokyo Station is showcasing a special exhibition dedicated to the popular anime series BLEACH, titled 'TV Anime BLEACH: THE BLOOD WARFARE – The Calamity.' The event runs from May 30, 2026, to August 16, 2026, and is located at Tokyu East 5 in Tokyo. The exhibition features key visuals from the 'BLEACH: Thousand-Year Blood War' TV series, life-size character […]

Fujitsu Limited has announced a field trial in collaboration with AEON Food Style Co., Ltd. to test an AI agent aimed at enhancing store operations. The initiative, part of Fujitsu's Uvance for Retail, seeks to address challenges within the retail sector, such as labor shortages and the reliance on individual expertise for store management. The trial, set to take place […]

Mitsubishi Heavy Industries, Ltd. (MHI) has demonstrated a measurable improvement in Power Usage Effectiveness (PUE) at the Fujitsu AKASHI Data Center, achieving a reduction in cooling energy consumption while maintaining stable operations. This initiative was conducted using multi-vendor infrastructure, adopting a holistic approach to cooling system control. Traditionally, data center cooling optimization has focused on individual equipment. However, MHI's project […]

Eisai Co., Ltd. and Biogen Inc. announced new data at the Alzheimer’s Association International Conference 2026 in London, revealing that the LEQEMBI (lecanemab) subcutaneous autoinjector formulation offers efficacy and safety comparable to intravenous administration for early Alzheimer’s disease treatment. The data, presented in the session titled “Lecanemab Subcutaneous Formulation in Early Alzheimer’s Disease: Emerging Clinical Evidence and Practical Use Considerations,” […]